618 related articles for article (PubMed ID: 8840989)
21. p53 protein accumulation in addition to the transactivation activity is required for p53-dependent cell cycle arrest after treatment of cells with camptothecin.
Jaks V; Jõers A; Kristjuhan A; Maimets T
Oncogene; 2001 Mar; 20(10):1212-9. PubMed ID: 11313865
[TBL] [Abstract][Full Text] [Related]
22. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
Sakoff JA; Howitt IJ; Ackland SP; McCluskey A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):225-32. PubMed ID: 14648018
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of induction of cell cycle arrest and cell death by cryptolepine in human lung adenocarcinoma a549 cells.
Zhu H; Gooderham NJ
Toxicol Sci; 2006 May; 91(1):132-9. PubMed ID: 16510557
[TBL] [Abstract][Full Text] [Related]
24. p21 is necessary for the p53-mediated G1 arrest in human cancer cells.
Waldman T; Kinzler KW; Vogelstein B
Cancer Res; 1995 Nov; 55(22):5187-90. PubMed ID: 7585571
[TBL] [Abstract][Full Text] [Related]
25. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
[TBL] [Abstract][Full Text] [Related]
26. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells.
Cayrol C; Knibiehler M; Ducommun B
Oncogene; 1998 Jan; 16(3):311-20. PubMed ID: 9467956
[TBL] [Abstract][Full Text] [Related]
27. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
Goldwasser F; Bae I; Fornace AJ; Pommier Y
Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
[TBL] [Abstract][Full Text] [Related]
28. Contrasting patterns of DNA fragmentation induced by thymidylate synthase inhibitors, ZD1694 and AG-331.
Panadero A; Yin MB; Voigt W; Rustum YM
Oncol Res; 1995; 7(2):73-81. PubMed ID: 7579730
[TBL] [Abstract][Full Text] [Related]
29. Repair Defect in p21 WAF1/CIP1 -/- human cancer cells.
McDonald ER; Wu GS; Waldman T; El-Deiry WS
Cancer Res; 1996 May; 56(10):2250-5. PubMed ID: 8625293
[TBL] [Abstract][Full Text] [Related]
30. The bacterial cytolethal distending toxin (CDT) triggers a G2 cell cycle checkpoint in mammalian cells without preliminary induction of DNA strand breaks.
Sert V; Cans C; Tasca C; Bret-Bennis L; Oswald E; Ducommun B; De Rycke J
Oncogene; 1999 Nov; 18(46):6296-304. PubMed ID: 10597228
[TBL] [Abstract][Full Text] [Related]
31. Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint.
Howard SP; Park SJ; Hughes-Davies L; Coleman CN; Price BD
Clin Cancer Res; 1996 Feb; 2(2):269-76. PubMed ID: 9816169
[TBL] [Abstract][Full Text] [Related]
32. Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation.
Pocard M; Chevillard S; Villaudy J; Poupon MF; Dutrillaux B; Remvikos Y
Oncogene; 1996 Feb; 12(4):875-82. PubMed ID: 8632910
[TBL] [Abstract][Full Text] [Related]
33. DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage.
Rathmell WK; Kaufmann WK; Hurt JC; Byrd LL; Chu G
Cancer Res; 1997 Jan; 57(1):68-74. PubMed ID: 8988043
[TBL] [Abstract][Full Text] [Related]
34. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
Giannakakou P; Robey R; Fojo T; Blagosklonny MV
Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.
Pietras RJ; Poen JC; Gallardo D; Wongvipat PN; Lee HJ; Slamon DJ
Cancer Res; 1999 Mar; 59(6):1347-55. PubMed ID: 10096569
[TBL] [Abstract][Full Text] [Related]
36. Involvement of bcl-2 and p21waf1 proteins in response of human breast cancer cell clones to Tomudex.
Orlandi L; Bearzatto A; Abolafio G; De Marco C; Daidone MG; Zaffaroni N
Br J Cancer; 1999 Sep; 81(2):252-60. PubMed ID: 10496350
[TBL] [Abstract][Full Text] [Related]
37. Levels of p53 in Epstein-Barr virus-infected cells determine cell fate: apoptosis, cell cycle arrest at the G1/S boundary without apoptosis, cell cycle arrest at the G2/M boundary without apoptosis, or unrestricted proliferation.
Chen W; Huang S; Cooper NR
Virology; 1998 Nov; 251(2):217-26. PubMed ID: 9837785
[TBL] [Abstract][Full Text] [Related]
38. Distinct p53-mediated G1/S checkpoint responses in two NIH3T3 subclone cells following treatment with DNA-damaging agents.
Huang TS; Kuo ML; Shew JY; Chou YW; Yang WK
Oncogene; 1996 Aug; 13(3):625-32. PubMed ID: 8760304
[TBL] [Abstract][Full Text] [Related]
39. 5-fluoro-2'-deoxyuridine-induced cdc25A accumulation correlates with premature mitotic entry and clonogenic death in human colon cancer cells.
Parsels LA; Parsels JD; Tai DC; Coughlin DJ; Maybaum J
Cancer Res; 2004 Sep; 64(18):6588-94. PubMed ID: 15374972
[TBL] [Abstract][Full Text] [Related]
40. Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SDI1/WAF1.
Bond JA; Blaydes JP; Rowson J; Haughton MF; Smith JR; Wynford-Thomas D; Wyllie FS
Cancer Res; 1995 Jun; 55(11):2404-9. PubMed ID: 7538902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
